Designation of the project | spinit® Commercial Expansion
Main goal | Reinforce research, technology development and innovation
Region of activity | Alentejo
Beneficiary | biosurfit S.A.

Approval date | 18-12-2018
Start date | 18-12-2018
End Date | 18-10-2020
Total eligible value | 4.994.881€


Project summary/ The main strategic goals of the project are:

The fast commercial expansion of the product offer in three main fronts:

• Development of new blood test panels using the current instrumentation platform;
• New blood test multi-parameter panels; 
• New range of spinit® instrumentation devices for new market segments.